Global market for blood-brain barrier (BBB) technology to reach $471.5 million in 2019

BBB technology is a sub-industry of the pharmaceutical sector. It is poised to open up vast untapped potential in the growing central nervous system therapeutic market, where today growth is limited by the complexity of this layer in the brain that prevents the passage of many potentially useful molecules/compounds.

BCC Research provides a detailed report on the blood-brain barrier (BBB) technology in its report, Blood Brain Barrier Technologies and Global Markets. According to this report, the global market for BBB technology amounted to $21.8 million in 2013 and is estimated to reach $38.7 million by 2014-end. This is further anticipated to reach $471.5 million by 2019, which is equivalent to 64.9% CAGR from 2014 through 2019.

RSS Feeds – Pharmaceuticals

Use this report for, but not limited to, the following reasons:

• Gain an overview of the global market for BBB therapeutics and technologies
• Analyze global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019
• Evaluate how blood-brain barrier technology will impact the pharmaceutical market
• Obtain information on applications, market values, growth potential, and significant trends for BBB technology
• Knowledge most pertinent to biotechnology and pharmaceutical industries and related life science, analytics, drug discovery, and diagnostic test manufacturing companies
• Review profiles of leading companies in the industry

SAMPLE FIGURE

GLOBAL MARKET FOR BBB TECHNOLOGY FOR THERAPEUTICS, 2012–2019

($ MILLIONS)

 

Click here to order your copy of this report (or any of its chapters) or to download the report overview chapter.